Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Palisade Bio, Inc. - Common Stock (NQ:PALI)

2.280 -0.060 (-2.56%)
Streaming Delayed Price Updated: 1:37 PM EDT, Apr 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Palisade Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Palisade Bio Announces Reverse Stock Split
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Palisade Bio Streamlines Operations To Focus Lead Clinical Program ↗
 
Via Benzinga
News headline image
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
News headline image
Palisade Bio Announces Executive Leadership Transition
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning! 
Via InvestorPlace
News headline image
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket ↗
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada. 
Via Benzinga
News headline image
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
  
Via Benzinga
News headline image
This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
News headline image
Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study ↗
Palisade Bio (NASDAQ: PALI) has dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
  
Via Benzinga
News headline image
Here's Why Palisade Bio Stock Is Getting Hammered Today ↗
Palisade Bio Inc (NASDAQ: PALI) shares are trading lower by 34.18% to $0.22 Friday morning after the company announced the pricing of a public offering for gross proceeds valued at approximately $12... 
Via Benzinga
News headline image
Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket ↗
Gainers Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 66.9% to $2.37 in pre-market trading. Neptune Wellness Solutions recently announced voluntary delisting from Toronto Stock Exchange. 
Via Benzinga
News headline image
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
News headline image
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
News headline image
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch! 
Via InvestorPlace
News headline image
Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗
 
Via Benzinga
News headline image
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
  
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Talis Biomedical (NASDAQ:TLIS) shares moved upwards by 10.6% to $0.94 during Tuesday's after-market session. The company's market cap stands at $25.0 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.